|
Jul 24
|
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
|
|
May 21
|
Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
|
|
Apr 17
|
Adicet Bio Appoints Michael Grissinger to the Board of Directors
|
|
Jan 31
|
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
|
Jan 29
|
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference
|
|
Dec 31
|
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
|